FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Diltiazem Hydrochloride Injection
Status: Resolved
»Duration of Shortage: 02/21/2018 - 05/22/2024
»Therapeutic Categories: Cardiovascular

Expand all

Hikma Pharmaceuticals USA, Inc. (Revised 05/22/2024)

Company Contact Information:
800-631-2174

Presentation

• Injection, 5 mg/1 mL (NDC 0641-6013-10)
• Injection, 5 mg/1 mL (NDC 0641-6014-10)
• Injection, 5 mg/1 mL (NDC 0641-6015-10)

Note:

• N/A

Hospira, Inc., a Pfizer Company (Revised 05/22/2024)

Company Contact Information:
844-646-4398

Presentation

• Diltiazem Hydrochloride, Injection, 100 mg (NDC 0409-4350-03)

Note:

• N/A

Sagent Pharmaceuticals (Reverified 05/22/2024)

Company Contact Information:
866-625-1618

Presentation

• Injection, 5 mg/1 mL (NDC 70860-301-05)
• Injection, 5 mg/1 mL (NDC 70860-301-10)
• Injection, 5 mg/1 mL (NDC 70860-301-25)

Note:

• N/A